Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Kevin Tang uses newfound control of Aurinia to finally take over Kezar

Kevin Tang uses newfound control of Aurinia to finally take over Kezar

  • March 30, 2026

Autoimmune specialist Aurinia, which named Kevin Tang as its new CEO last week, is acquiring Kezar after the latter company received promising feedback from the FDA. Tang previously made an unsuccessful attempt in 2024 to acquire Kezar via Concentra Biosciences and its parent company, Tang Capital Partners.

Leave A Comment

Fields (*) Mark are Required